Concierge gives you timely BUY and SELL alerts on ASX-listed stocks
Emerging Stocks Down Under 30 November 2021: Nearmap, Clarity Pharmaceuticals, Pacific Edge
Nearmap: Medium term upside in a downtrend
In today’s edition of Emerging Stocks Down Under, aerial imaging company Nearmap has been on a longer term downtrend. But we believe there may be upside to $1.90-2.00 within that downtrend in the near to medium term.
Also in today’s edition, radiopharmaceutical company Clarity Pharmaceuticals (ASX: CU6) and cancer diagnostics company Pacific Edge (ASX: PEP).
Click here to read the previous edition of Emerging Stocks Down Under published 23 November 2021
For in-depth research reports or to keep up-to-date on the latest Stocks Down Under news see our parent company, Pitt Street Research, or follow us on Facebook and Twitter.